1.Effects of tretinoin pretreatment on TCA chemical peel in guinea pig skin.
Il Hwan KIM ; Han Kyeom KIM ; Young Chul KYE
Journal of Korean Medical Science 1996;11(4):335-341
This study was done to characterize the structural changes in the tretinoin pretreatment on trichloroacetic acid(TCA) chemical peel. In guinea pigs, the right halves pretreated with tretinoin and the left halves treated nothing were compared in their structural changes after TCA chemical peel. Epidermal thickness in the tretinoin pretreated group was almost the same in the first and second week. But epidermis of the TCA group increased continuously. In the first week, mitotic figures in the epidermis were more increased in the TCA group, but those in hair follicles were more increased in the tretinoin pretreated group. In the second week, mitotic figures in the epidermis were almost same in both group, but in hair follicles of the tretinoin pretreated group, mitotic figures were much more increased. In alcian blue staining, glycosaminoglycan was stained much more strongly in dermis of the TCA group in first week, but was more strongly stained in the tretinoin pretreated group in second week. On electron microscopic findings, the fibroblasts in upper dermis were larger and had plentier cytoplasm with more organelles in the tretinoin pretreated group. Conclusively, tretinoin pretreatment on TCA chemical peel sustained the effects of TCA longer and showed synergistic effects of TCA and induced enhanced wound healing.
Animal
;
Epidermis/drug effects/pathology
;
Guinea Pigs
;
Skin/*drug effects/pathology
;
Tretinoin/*pharmacology
;
Trichloroacetic Acid/*pharmacology
3.Drug Hypersensitivity to Previously Tolerated Phenytoin by Carbamazepine-induced DRESS Syndrome.
Cheol Woo KIM ; Gwang Seong CHOI ; Chang Ho YUN ; Deok In KIM
Journal of Korean Medical Science 2006;21(4):768-772
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome associated with anticonvulsant drugs is a rare but potentially life-threatening disease that occurs in response to arene oxide producing anticonvulsant such as phenytoin and carbamazepine. There have been many reports of cross reactivity among the anticonvulsants upon first exposure to the offending drugs. However, there has been few data describing the development of DRESS syndrome after switching medication from previously well-tolerated phenytoin to carbamazepine, and the induction of hypersensitivity to phenytoin by DRESS to carbamazepine. We experienced a case of a 40-yr-old man who had uncontrolled seizure that led to the change of medication from the long-term used phenytoin to carbamazepine. He developed DRESS syndrome after changing the drugs. We stopped carbamazepine and restored phenytoin for seizure control, but his clinical manifestations progressively worsened and he recovered only when both drugs were discontinued. Patch tests with several anticonvulsants showed positive reactions to both carbamazepine and phenytoin. Our case suggests that hypersensitivity to a previously tolerated anticonvulsant can be induced by DRESS to another anticonvulsant, and that the patch test may be a useful method for detecting cross-reactive drugs in anticonvulsant-associated DRESS syndrome.
Syndrome
;
Skin/drug effects/immunology/pathology
;
Phenytoin/immunology
;
Male
;
Humans
;
Drug Hypersensitivity/*immunology
;
Drug Eruptions/etiology/*immunology
;
Carbamazepine/*adverse effects
;
Anticonvulsants/adverse effects
;
Adult
4.Laboratory research of the influence of keyouling on the proliferation of human prepuce epidermis cells and condyloma acuminatum cells.
Yi JIANG ; Shuwu ZHANG ; Jiuyuan WANG ; Kaicheng WAN ; Caiming WANG
National Journal of Andrology 2004;10(3):237-239
OBJECTIVETo discuss the mechanism of the Chinese medicine Keyouling in the treatment of condyloma axuminatum (CA).
METHODSHuman prepuce epidermis cells and CA cells were primarily cultured and subcultured. We determined the proliferation of human prepuce epidermis cells and CA cells, and observed the influence of Keyouling with different concentrations on the proliferation of human prepuce epidermis cells and CA cells by means of MTT colourimetry assay.
RESULTSThe absorbance was directly proportional to the numbers of human prepuce epidermis cells (r = 0.9850, P < 0.001) and CA cells (r = 0.9892, P < 0.001). Keyouling had no effect on proliferation of the human prepuce epidermis cells, but it had significant inhibition on CA cells. The concentrations of Keyouling bore negative correlation with the proliferation percentage of CA cells(r = -0.4124, P < 0.01).
CONCLUSIONKeyouling can significantly restrain the growth and proliferation of CA cells but has no damaging effect on normal organic cuticle cells. It is suggested that Keyouling might have anti-HPV effect.
Adolescent ; Adult ; Cell Division ; drug effects ; Condylomata Acuminata ; drug therapy ; pathology ; Dose-Response Relationship, Drug ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Humans ; Male ; Middle Aged ; Penile Diseases ; drug therapy ; pathology ; Penis ; drug effects ; Skin ; drug effects
5.Effect of Recombinant Human Epidermal Growth Factor Against Cutaneous Scar Formation in Murine Full-thickness Wound Healing.
Young Seok KIM ; Dae Hyun LEW ; Kwan Chul TARK ; Dong Kyun RAH ; Joon Pio HONG
Journal of Korean Medical Science 2010;25(4):589-596
A visible cutaneous scar develops from the excess formation of immature collagen in response to an inflammatory reaction. This study examined the role of epidermal growth factor (EGF) in the formation of cutaneous scars. Twenty Crl:CD-1 (ICR) mice were used and 2 full-thickness skin wounds were made on the dorsum of each mouse. One of the wounds was treated with recombinant human EGF by local application and the other was treated with saline for control until complete healing was achieved. The EGF-treated group's wounds healed faster than the control group's. The width of the scar was smaller by 30% and the area was smaller by 26% in the EGF-treated group. Inflammatory cell numbers were significantly lower in the EGF-treated group. The expression of transforming growth factor (TGF)-beta1 in the EGF-treated group was increased. It was observed that the amount of collagen in the EGF-treated group was larger than the control group. In the EGF-treated group, the visible external scars were less noticeable than that in the control group. These results suggest that EGF can reduce cutaneous scars by suppressing inflammatory reactions, decreasing expression of TGF-beta1, and mediating the formation of collagen.
Animals
;
Cicatrix/pathology/*prevention & control
;
Collagen/metabolism
;
Epidermal Growth Factor/*pharmacology
;
Humans
;
Inflammation/metabolism
;
Mice
;
Recombinant Proteins/*pharmacology
;
Skin/drug effects/metabolism/pathology
;
Wound Healing/*drug effects
6.Acitretin induces apoptosis and changes of relative signaling pathway in epidermoid carcinoma cell line A431.
Sui-qing CAI ; Li-rong CHEN ; Min ZHENG
Journal of Zhejiang University. Medical sciences 2006;35(2):182-188
OBJECTIVETo study the effects of Acitretin on growth inhibition and apoptosis of epidermoid carcinoma cell line A431 and its molecular mechanisms.
METHODSA431 cells were treated with Acitretin at the concentration of 10(-5)mol/L in different time intervals. The inhibition of cell growth was determined by MTT method, morphological changes were observed by electron microscopy, apoptosis was assessed by flow cytometry and Annexin-V staining. The mRNA expression levels of STAT3, cyclinD1 and p42/44MAPK were detected by reverse transcriptase polymerase chain reaction (RT-PCR). The protein expression levels of P-STAT3 and CyclinD1 were observed by Western blot in A431 cells.
RESULT(1)Acitretin inhibited the growth of A431 cells in vitro in a dose-and time-dependent manner. Morphological changes revealed characteristics of cell apoptosis. Flow cytometry showed more sub-G(1) phase in A431 cells and more cells positively stained with Annexin-V. (2)Acitretin significantly inhibited the expression of STAT3 and CyclinD1 mRNA in A431 cells in vitro in a time-dependent manner(P<0.05). The p-STAT3 and CyclinD1 protein levels were down regulated. The Acitretin could also down regulate the p42/4MAPK mRNA in A431 cells. (3) After incubation with Acitretin, the mRNA level of CyclinD1 in A431 cells was positively correlated with that of STAT3(p<0.05). The protein level of CyclinD1 was also positively correlated with that of p-STAT3(p<0.05). However, there was no correlation between Mrna levels of CyclinD1 and p42/44MAPK.
CONCLUSION(1)Acitretin plays an inhibitory role in the tumor cell growth and induces the cell apoptosis in A431 cells. (2)The regulation of the Jak/STAT3 signaling pathway may play an important role in inducing growth inhibition and apoptosis by Acitretin in A431 cells.
Acitretin ; pharmacology ; Antineoplastic Agents ; pharmacology ; Apoptosis ; drug effects ; Carcinoma, Squamous Cell ; pathology ; Cell Line, Tumor ; Humans ; Signal Transduction ; drug effects ; Skin Neoplasms ; pathology
7.Quinupristin/Dalfopristin-induced Sweet's Syndrome.
Hye Sook CHOI ; Hee Jin KIM ; Tae Hee LEE ; Sang Hoon LEE ; Tae Won LEE ; Chun Gyoo IHM ; Myung Jae KIM
The Korean Journal of Internal Medicine 2003;18(3):187-190
Quinupristin/Dalfopristin is a new combination of streptogramin antibiotics designed specifically to treat clinically significant infections due to Vancomycin-resistant Enterococcus Faecium. Sweet's syndrome is characterized by painful skin plaques, which is associated with dermal neutrophilic infiltration, fever and peripheral blood leukocytosis. Drug-induced Sweet's syndrome has a temporal relationship between drug ingestion, clinical presentation and the temporally-related resolution of lesions following drug withdrawal or on treatment with systemic corticosteroids. A 63-year-old woman received Quinupristin/Dalfopristin for acute pyelonephritis developed fever, arthralgia, vomiting, and painful erythematous skin plaques. A skin biopsy showed neutrophilic dermatosis, and there was rapid resolution of the symptoms and cutaneous lesions after discontinuation of Quinupristin/Dalfopristin, consistent with drug-induced Sweet's syndrome. To date, there has been no reported case of Sweet's syndrome associated with the use of Quinupristin/Dalfopristin.
Anti-Bacterial Agents/administration & dosage/*adverse effects
;
Female
;
Human
;
Middle Aged
;
Skin/drug effects/pathology
;
Sweet's Syndrome/*chemically induced/pathology
;
Virginiamycin/administration & dosage/*adverse effects/*analogs & derivatives
8.Ciprofloxacin: an uncommon drug reaction to a commonly used drug.
Pedro MENDES-BASTOS ; Rodrigo CARVALHO ; Daniela CUNHA ; Jorge CARDOSO
The Korean Journal of Internal Medicine 2014;29(2):263-264
No abstract available.
Aged, 80 and over
;
Anti-Bacterial Agents/*adverse effects
;
Ciprofloxacin/*adverse effects
;
Drug Eruptions/diagnosis/*etiology
;
Female
;
Humans
;
Skin/*drug effects/pathology
9.Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site.
Wen Chun LIU ; Hong Liang TEY ; Joyce Siong See LEE ; Boon Kee GOH
Singapore medical journal 2014;55(1):e1-3
The diagnosis of exogenous ochronosis is often challenging and requires a high index of suspicion. Herein, we report a case of exogenous ochronosis in a Chinese patient. The condition was caused by the use of bleaching agents, including creams containing hydroquinone. We demonstrate the use of dermoscopy as an invaluable tool for the early recognition of the condition, as well as in the selection of an appropriate site for a skin biopsy.
Alkaptonuria
;
Biopsy
;
Bleaching Agents
;
adverse effects
;
China
;
Dermoscopy
;
methods
;
Humans
;
Hydroquinones
;
adverse effects
;
Male
;
Melanosis
;
drug therapy
;
Middle Aged
;
Ochronosis
;
diagnosis
;
therapy
;
Skin
;
drug effects
;
pathology
;
Treatment Outcome
10.Experimental study on removal melanin granules from acellular dermal matrix of giant nevus.
Qian LIU ; Chen ZHANG ; Linbo LIU
Chinese Journal of Plastic Surgery 2014;30(2):122-125
OBJECTIVETo study the possibility of removal melanin granules from autogenic acellular dermal matrix of giant nevus tissue by H2O2 bleaching technique.
METHODSA total of 32 skin specimens (0.5 cm x 0.5 cm) from giant nevus tissue and 1 piece (0.5 cm x 0.5 cm) of normal skin were obtained from the surgical removal. One giant nevus tissue was chosen as control. The others and the normal skin tissue were treated with solution of 0.25% Dispase II for digestion for 24 hours under normal temperature to remove epidermis. Then each piece was immerged into solution of 0.5% Triton X-100 for digestion for 48 hours in normal temperature. One giant nevus tissue and the normal skin tissue were chosen as control. The others were immerged into solution of different concentrations of H2O2, treated under different temperature and lasting for different period. Lastly, all specimens were treated with HE staining, immunohistochemical staining, light microscopy and so on.
RESULTSAfter giant nevus tissues were treated with solution of 0.25% Dispase II and immerged into solution of 0.5% Triton X-100 in normal temperature, nevus cells and all other cellular components of pigmented nevus tissues can be effectively removed, there were the cavities left by removal of cells without any residual cell debris, but still remaining part of pigment. Then each specimen were immerged into solution of different concentrations of H2O2, under different temperature and lasting for different period which can remove residual melanin granules. In solution of 3% H2O2 for 36 h under 37 degrees C, can remove all the melanin particles, the content of collagen type I in the obtained specimen was not changed. Collagen fibers were uniform in thickness, regular in arrangement with no obvious degeneration.
CONCLUSIONSWith solution of 0.25% Dispase II and solution of 0.5% Triton X-100 in normal temperature, all cells in nevus tissue can be removed effectively. Further treatment with 3% H2O2 at 37 degrees C for 36 h can remove all the melanin particles, while collagen type I has no obvious change. The preparation of acellular dermal matrix of the giant nevus may possibly be applied as autologous tissue implant to repair tissue defects.
Acellular Dermis ; Endopeptidases ; pharmacology ; Epidermis ; Humans ; Hydrogen Peroxide ; pharmacology ; Melanins ; Nevus ; pathology ; Nevus, Pigmented ; pathology ; Octoxynol ; pharmacology ; Skin Lightening Preparations ; pharmacology ; Skin Neoplasms ; pathology ; Skin Pigmentation ; drug effects ; Skin Transplantation ; Surface-Active Agents ; pharmacology